Orthofix Medical Inc.
Income Statement
| Line Item | Jul 2026 | Jun 2026 | May 2026 | Mar 2026 | Feb 2026 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $210.9M | — | $196.7M | — | — | — | $205.6M |
| Cost of Revenue | — | $61.2M | — | $57.2M | — | — | — | $57.1M |
| Gross Profit | — | $149.7M | — | $139.5M | — | — | — | $148.5M |
| Gross Margin | — | 71.0% | — | 70.9% | — | — | — | 72.2% |
| Operating Expenses | ||||||||
| Research & Development | — | $15.9M | — | $15.3M | — | — | — | $14.8M |
| SG&A Expense | — | $138.0M | — | $134.9M | — | — | — | $148.1M |
| Operating Income | — | $-8.1M | — | $-14.4M | — | — | — | $-17.0M |
| Operating Margin | — | -3.9% | — | -7.3% | — | — | — | -8.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-15.0M | — | $-20.8M | — | — | — | $-22.3M |
| Income Tax Expense | — | $801.0K | — | $74.0K | — | — | — | $533.0K |
| Net Income | — | $-15.8M | — | $-20.9M | — | — | — | $-22.8M |
| Net Margin | — | -7.5% | — | -10.6% | — | — | — | -11.1% |
| EPS (Basic) | — | $-0.39 | — | $-0.52 | — | — | — | $-0.57 |
| EPS (Diluted) | — | $-0.39 | — | $-0.52 | — | — | — | $-0.57 |
| Shares Outstanding (Basic) | 40.7M | 40.9M | 40.4M | 40.5M | 40.1M | 39.8M | 39.6M | 39.8M |
| Shares Outstanding (Diluted) | 40.7M | 40.9M | 40.4M | 40.5M | 40.1M | 39.8M | 39.6M | 39.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |